CN101843700A - Chinese medicament for treating coronary disease - Google Patents
Chinese medicament for treating coronary disease Download PDFInfo
- Publication number
- CN101843700A CN101843700A CN200910235494A CN200910235494A CN101843700A CN 101843700 A CN101843700 A CN 101843700A CN 200910235494 A CN200910235494 A CN 200910235494A CN 200910235494 A CN200910235494 A CN 200910235494A CN 101843700 A CN101843700 A CN 101843700A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese
- chinese medicine
- chinese medicament
- fine powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicament for treating a coronary disease, and belongs to the field of Chinese medicaments for treating cardio-cerebral-vascular system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: peach seed, radix pseudo-ginseng, white paeony root, Szechuan lovage rhizome, root of rehmannia, lucid ganoderma and Chinese angelica. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and yin, activating blood and dissolving stasis, and nourishing heart and soothing nerves, and has the advantages of obvious effect, exact medicinal effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of cardiovascular and cerebrovascular systems.
Background technology
Be intended to treat the field of Chinese medicines of coronary heart disease at present, have the deficiency of two aspects: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.Many patients with coronary heart disease are stood the torment of feeling of oppression and pain in the chest for a long time, face the danger of myocardial infarction, and patient and family members thereof are satisfied inadequately to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of coronary heart disease, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of coronary heart disease adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Semen Persicae 4-30 part Radix Notoginseng 3-25 part Radix Paeoniae Alba 3-25 part
Rhizoma Chuanxiong 4-30 part Radix Rehmanniae 4-30 part Ganoderma 2-15 part
Radix Angelicae Sinensis 3-25 part
The Chinese medicine of this treatment coronary heart disease is made by following method:
(1) by above-mentioned weight ratio, Semen Persicae, the Radix Paeoniae Alba, Rhizoma Chuanxiong, the Radix Rehmanniae, Radix Angelicae Sinensis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.The traditional Chinese medical science thinks that angina pectoris belongs to deficiency of both QI and YIN, the resistance of the heart arteries and veins stasis of blood more, just thinks supplementing QI and nourishing YIN, blood circulation promoting and blood stasis dispelling.Ganoderma vigorate qi and replenish the blood in the side, tranquilizing by nourishing the heart, the body resistance strengthening and constitution consolidating, this is a principal agent; Symphysis ground, Radix Paeoniae Alba supplementing QI and nourishing YIN; Radix Angelicae Sinensis, Rhizoma Chuanxiong, Semen Persicae blood circulation promoting and blood stasis dispelling; Assistant is with the Radix Notoginseng blood-activating analgetic.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, supplementing QI and nourishing YIN, and blood circulation promoting and blood stasis dispelling, the merit of tranquilizing by nourishing the heart, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
The Semen Persicae 80 gram Radix Notoginseng 60 gram Radix Paeoniae Albas 60 grams
The Rhizoma Chuanxiong 80 gram Radix Rehmanniae 80 kairine sesames 40 grams
Radix Angelicae Sinensis 60 grams
Weight in accordance with regulations, with conventional water extraction process Semen Persicae, the Radix Paeoniae Alba, Rhizoma Chuanxiong, the Radix Rehmanniae, Radix Angelicae Sinensis are extracted, make extractum fine powder 108 grams, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 742 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
The Semen Persicae 150 gram Radix Notoginseng 150 gram Radix Paeoniae Albas 120 grams
The Rhizoma Chuanxiong 150 gram Radix Rehmanniae 150 kairine sesames 100 grams
Radix Angelicae Sinensis 120 grams
By above-mentioned same method, make 1632 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
The Semen Persicae 300 gram Radix Notoginseng 250 gram Radix Paeoniae Albas 250 grams
The Rhizoma Chuanxiong 300 gram Radix Rehmanniae 300 kairine sesames 150 grams
Radix Angelicae Sinensis 250 grams
By above-mentioned same method, make 2928 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
5 parts of 4 portions of Radix Paeoniae Albas of 6 portions of Radix Notoginseng of Semen Persicae
3 parts of 6 portions of Ganodermas of 6 parts of Radix Rehmanniae of Rhizoma Chuanxiong
5 parts of Radix Angelicae Sinensis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
20 parts of 20 portions of Radix Paeoniae Albas of 20 portions of Radix Notoginseng of Semen Persicae
10 parts of 20 portions of Ganodermas of 20 parts of Radix Rehmanniae of Rhizoma Chuanxiong
15 parts of Radix Angelicae Sinensis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science coronary heart disease, through 12 routine clinical observations.Selecting tcm diagnosis coronary heart disease is standard: have a delicate constitution, limb is soft weak, and feeling of oppression and pain in the chest is dizzy nervous, the Electrocardioscopy myocardial ischemia.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 6 examples, women's 6 examples do not have other serious disease, and the age is 47 years old-81 years old, 61.2 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, and on one's body energetically, cardiac distresses such as feeling of oppression and pain in the chest are obviously alleviated, and the visible blood supply of cardiac muscle of electrocardiogram obviously improves.
2, effective: body constitution strengthens, and cardiac distresses such as feeling of oppression and pain in the chest are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 3 months after, symptom is obviously improved.12 philtrums of clinical experiment, produce effects 5 people, effective 6 people, invalid 1 people, total effective rate 91.6%.
Claims (1)
1. a Chinese medicine for the treatment of coronary heart disease adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Semen Persicae 4-30 part Radix Notoginseng 3-25 part Radix Paeoniae Alba 3-25 part
Rhizoma Chuanxiong 4-30 part Radix Rehmanniae 4-30 part Ganoderma 2-15 part
Radix Angelicae Sinensis 3-25 part
The Chinese medicine of this treatment coronary heart disease is made by following method:
(1) by above-mentioned weight ratio, Semen Persicae, the Radix Paeoniae Alba, Rhizoma Chuanxiong, the Radix Rehmanniae, Radix Angelicae Sinensis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910235494A CN101843700A (en) | 2009-10-16 | 2009-10-16 | Chinese medicament for treating coronary disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910235494A CN101843700A (en) | 2009-10-16 | 2009-10-16 | Chinese medicament for treating coronary disease |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101843700A true CN101843700A (en) | 2010-09-29 |
Family
ID=42768636
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910235494A Pending CN101843700A (en) | 2009-10-16 | 2009-10-16 | Chinese medicament for treating coronary disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101843700A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102669348A (en) * | 2012-05-20 | 2012-09-19 | 北京绿源求证科技发展有限责任公司 | Nutrition food of heart nourishing tea granule for nourishing heart |
-
2009
- 2009-10-16 CN CN200910235494A patent/CN101843700A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102669348A (en) * | 2012-05-20 | 2012-09-19 | 北京绿源求证科技发展有限责任公司 | Nutrition food of heart nourishing tea granule for nourishing heart |
CN102669348B (en) * | 2012-05-20 | 2013-06-12 | 北京绿源求证科技发展有限责任公司 | Nutrition food of heart nourishing tea granule for nourishing heart |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101554470A (en) | Traditional Chinese medicine for treating tachycardia | |
CN101843660B (en) | Chinese medicament for treating tachycardia | |
CN101843712B (en) | Chinese medicament for treating angina | |
CN101843717B (en) | Chinese medicament for treating coronary disease | |
CN101850055B (en) | Chinese medicament for treating coronary heart diseases | |
CN101843644B (en) | Chinese medicament for treating tachycardia | |
CN101843755A (en) | Chinese medicament for treating diabetic cardiopathy | |
CN101843700A (en) | Chinese medicament for treating coronary disease | |
CN101843758B (en) | Chinese medicament for treating coronary disease | |
CN101843753B (en) | Chinese medicament for treating angina | |
CN101843807A (en) | Chinese medicament for treating diabetic cardiopathy | |
CN101843835B (en) | Chinese medicament for treating coronary diseases | |
CN101843832B (en) | Chinese medicament for treating coronary disease | |
CN101843793B (en) | Chinese medicament for treating tachycardia | |
CN101843645B (en) | Chinese medicament for treating tachycardia | |
CN101564476B (en) | Chinese medicament for treating coronary heart disease | |
CN101849985B (en) | Chinese medicament for treating tachycardia | |
CN101843647B (en) | Chinese medicament for treating angina | |
CN101554441A (en) | Traditional Chinese medicine for treating coronary heart disease | |
CN101843720B (en) | Chinese medicament for treating angina | |
CN101850054B (en) | Chinese medicament for treating diabetic heart diseases | |
CN101843797A (en) | Chinese medicament for treating pulmonary heart diseases | |
CN101843679A (en) | Chinese medicament for treating cervical spondylosis | |
CN101537068A (en) | Chinese medicine for treating angina | |
CN101843730A (en) | Chinese medicament for treating coronary disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20100929 |